Elsophie Wart Corn Remover

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for the treatment of corns, calluses, flat warts, plantar warts, and common warts measuring less than 5 mm in diameter.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The corn warts should be soaked in warm water for 5 minutes prior to treatment. After soaking, the skin must be dried thoroughly. The brush should be installed into the bottle cap and pressed tightly to ensure a secure fit. Once the brush is prepared, the lid of the bottle can be opened.

The liquid should be dipped using the brush and applied directly onto the wart or corn. It is important to wait for a mask to form before applying the liquid again. The application should be performed twice during the day and twice at night.

Treatment should continue for a duration of 2 weeks, or until the skin has recovered its health. In cases where corns or warts are particularly large, an extended treatment period may be necessary.

Contraindications

The product is contraindicated for use in the eye area. It should not be applied to the face or healthy skin, as it is intended for external use only.

Patients with a known allergy to this product should discontinue use immediately. If symptoms persist for more than 7 days or worsen, consultation with a physician is advised. In the event of contact with the eyes, the area should be flushed with water immediately.

Warnings and Precautions

For external use only; it is imperative to avoid contact with the face or any healthy skin. In the event of contact with the eyes, the affected area should be flushed with water immediately to mitigate potential irritation.

Healthcare professionals should advise patients to discontinue use and consult a physician if they experience any allergic reactions to the product. Additionally, if symptoms persist for more than 7 days or worsen, it is essential to seek medical advice promptly.

Side Effects

Patients using this product should be aware that it is intended for external use only. Care should be taken to avoid contact with the face or healthy skin. In the event of contact with the eyes, it is recommended to flush the area with water immediately.

In clinical practice, patients are advised to discontinue use if they experience any allergic reactions to the product. Additionally, if symptoms persist for more than 7 days or worsen, it is important for patients to consult their physician for further evaluation and guidance.

These precautions are essential to ensure the safety and well-being of patients using the product.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Elsophie Wart Corn Remover (wart corn remover liquid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely, and the medication must be kept out of reach of children to prevent accidental ingestion. It is essential for healthcare professionals to educate caregivers about the importance of safe storage practices to minimize the risk of exposure in pediatric populations.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The product has not been evaluated for safety in pregnancy, and caution is advised due to the lack of established safety data regarding the use of salicylic acid during this period. While specific contraindications are not stated, potential risks associated with the use of salicylic acid during pregnancy remain undetailed in the prescribing information.

Healthcare professionals should be aware that no specific dosage modifications for pregnant individuals are provided. It is recommended that pregnant patients or those planning to become pregnant consult a physician prior to using this product to ensure appropriate guidance and risk assessment.

Lactation

There is no specific information regarding the use of ELSOPHIE WART CORN REMOVER in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this product.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement standard supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Continuous assessment and supportive care are critical in managing the patient's condition effectively.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities and to consult relevant clinical guidelines for further management strategies.

Nonclinical Toxicology

No relevant information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no pertinent data concerning nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion or misuse. It is important to inform patients that the product is for external use only and should not be applied to the eye area. Patients should be cautioned to avoid contact with the face or any healthy skin.

In the event that the product comes into contact with the eyes, patients should be instructed to flush the area with water immediately. Additionally, healthcare providers should emphasize the importance of consulting a physician if the patient experiences any allergic reactions to the product, if symptoms persist for more than 7 days, or if symptoms worsen. This guidance is crucial for ensuring patient safety and effective use of the product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at room temperature, within the range of 15–30°C (59–86°F). Care should be taken to avoid exposure to direct sunlight or excessive heat to maintain product integrity. Proper storage conditions are essential to ensure the efficacy and safety of the product.

Additional Clinical Information

The medication is administered topically, with a recommended frequency of twice during the day and twice at night. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Elsophie Wart Corn Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)